Organogenesis Inc.

NASDAQ: ORGO · Real-Time Price · USD
4.72
0.02 (0.43%)
At close: Aug 15, 2025, 3:59 PM
4.80
1.59%
After-hours: Aug 15, 2025, 05:16 PM EDT

Organogenesis Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-8.23M -15.88M 861K -7.38M -16.55M 5.81M 4.95M 13M 10.05M 12.48M 15.53M 59.74M 72.1M 85.05M 94.9M 61.7M 70.06M 44.2M
Depreciation & Amortization
21.68M 21.31M 21.2M 21.11M 20.48M 19.74M 19.42M 17.65M 18.39M 19.48M 18.03M 18.3M 18.52M 17.71M 16.68M 14.05M 11.16M 9.13M
Stock-Based Compensation
11.51M 11.54M 10.58M 10.05M 9.76M 9.49M 9M 8.48M 7.77M 7.16M 6.55M 5.78M 5.12M 4.47M 3.86M 3.28M 2.72M 2.15M
Other Working Capital
-52.96M -38.77M -20.15M -31.77M -7.56M -7M -15.32M -12.42M -18.07M -15.27M -19.16M -12.44M -8.47M -11.75M -3.6M -2.58M -2.95M 2.94M
Other Non-Cash Items
28.64M 42.67M 35.49M 35.05M 30.87M 10.59M 8.47M 8.55M 15.02M 16.28M 16.85M 18.09M 10.28M 9.88M 10.08M 8.21M 7.27M 5.64M
Deferred Income Tax
-7.32M -6.3M -5.03M -186K 5.25M 7.16M 7.16M 7.12M 3.88M 1.98M 1.98M -31.98M -25.17M -26.88M -25.83M 6.25M 1.04M 3.5M
Change in Working Capital
-79.46M -48.9M -48.89M -44.76M -27.89M -26.95M -18.07M -26.7M -38.29M -39.01M -34.08M -34.93M -23.44M -25.35M -37.71M -23.19M -42.65M -42.02M
Operating Cash Flow
-33.18M 4.43M 14.21M 13.88M 21.92M 25.83M 30.92M 28.1M 16.82M 18.37M 24.86M 35.01M 57.4M 64.87M 61.98M 70.31M 49.6M 22.61M
Capital Expenditures
-13.19M -11.44M -10.03M -9.99M -13.4M -19.02M -24.36M -31.7M -36.12M -34.79M -33.9M -28.47M -34.77M -32.94M -31.22M -34.88M -24.02M -21.86M
Cash Acquisitions
n/a n/a n/a -1.66M -828K n/a n/a 1.66M 828K n/a n/a n/a n/a n/a n/a -5.82M -5.82M -5.82M
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a 1.66M 828K n/a n/a -1.66M -828K n/a n/a n/a n/a -179K n/a 6.23M 1.84M 2.31M
Investing Cash Flow
-13.19M -11.44M -10.03M -9.99M -13.4M -19.02M -24.36M -31.7M -36.12M -34.79M -33.9M -28.47M -34.77M -33.11M -31.22M -34.47M -28M -25.37M
Debt Repayment
-64.88M -66.26M -67.64M -6.8M -6.56M -5.9M -5.17M -5.27M -3.83M -3.38M -3.01M -2.14M -1.78M -1.91M -2.01M -31.02M -32.01M -26.04M
Common Stock Repurchased
-25.48M -25.48M -25.48M 333K 333K 333K 333K n/a -2K -160K -160K -160K -158K n/a n/a n/a n/a n/a
Dividend Paid
-4.61M -1.8M -1.8M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
99.26M 96.4M 97.08M -1.17M -1.17M -1.15M -332K -333K -306K 713K 814K 897K 1.78M 697K 978K 65.14M 64.08M 63.81M
Financial Cash Flow
29.63M 28.19M 27.64M -7.79M -7.55M -6.88M -5.5M -5.6M -4.14M -2.67M -2.2M -1.24M 3K -1.21M -1.04M 30M 27.96M 33.65M
Net Cash Flow
-16.74M 21.19M 31.81M -3.9M 969K -69K 1.05M -9.2M -23.44M -19.09M -11.24M 5.3M 22.64M 30.54M 29.72M 65.84M 49.55M 30.88M
Free Cash Flow
-46.37M -7M 4.18M 3.89M 8.52M 6.81M 6.55M -3.59M -19.3M -16.42M -9.04M 6.54M 22.63M 31.93M 30.76M 35.43M 25.57M 746K